114772-39-3
|
文献:Merck and Co., Inc. Patent: US5250521 A1, 1993 ; US 5250521 A
|
114772-39-3
|
文献:Merck and Co., Inc. Patent: US5332744 A1, 1994 ; US 5332744 A
|
114772-39-3
|
文献:Elf Sanofi Patent: US5270317 A1, 1993 ; US 5270317 A
|
114772-39-3
|
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Brodrecht, Martin; Pilakowski, Johannes; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris European Journal of Medicinal Chemistry, 2013 , vol. 61, p. 26 - 40
|
114772-39-3
|
文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Brodrecht, Martin; Pilakowski, Johannes; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris European Journal of Medicinal Chemistry, 2013 , vol. 61, p. 26 - 40
|
114772-39-3
|
文献:Carini, David J.; Duncia, John V.; Aldrich, Paul E.; Chiu, Andrew T.; Johnson, Alexander L.; et al. Journal of Medicinal Chemistry, 1991 , vol. 34, # 8 p. 2525 - 2547
|
114772-39-3
|
文献:Penchant; Demphel; Hinnen; Crouzel European Journal of Medicinal Chemistry, 1997 , vol. 32, # 9 p. 747 - 752
|